Open AccessIntralesional bleomycin in lymphangioma: An effective and safe non-operative modality of treatment
Author(s) -
Vijayendra Kumar,
Puneet Kumar,
Anand Pandey,
DK Gupta,
Ram Chandra Shukla,
Seema Sharma,
A. N. Gangopadhyay
Publication year - 2012
Publication title -
journal of cutaneous and aesthetic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.44
H-Index - 13
eISSN - 0974-5157
pISSN - 0974-2077
DOI - 10.4103/0974-2077.99456
Subject(s) - medicine , lymphangioma , bleomycin , surgery , bleed , lymphatic system , radiology , prospective cohort study , sclerotherapy , radiation therapy , chemotherapy , pathology
Lymphangiomas are benign hamartomatous lymphatic tumors. The mainstay of the therapy is surgical excision, but due to its infiltration along the nerves and muscles, total excision is not always possible. In the present study, we have evaluated the clinical profile of all the cases of lymphagiomas coming to our department and evaluated the efficacy of intralesional Bleomycin as a sclerosing agent in its management.